The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
2011 Alzheimer's disease facts and figures
Abstract
Alzheimer's disease (AD) is the sixth leading cause of all deaths in the United States and is the fifth leading cause of death in Americans aged ≥65 years. Although other major causes of death have been on the decrease, deaths because of AD have been rising dramatically. Between 2000 and 2008 (preliminary data), heart disease deaths decreased by 13%, stroke deaths by 20%, and prostate cancer‐related deaths by 8%, whereas deaths because of AD increased by 66%. An estimated 5.4 million Americans have AD; approximately 200,000 people aged <65 years with AD comprise the younger‐onset AD population. Every 69 seconds, someone in America develops AD; by 2050, the time is expected to accelerate to every 33 seconds. Over the coming decades, the baby boom population is projected to add 10 million people to these numbers. In 2050, the incidence of AD is expected to approach nearly a million people per year, with a total estimated prevalence of 11 to 16 million people. Dramatic increases in the numbers of “oldest‐old” (those aged ≥85 years) across all racial and ethnic groups will also significantly affect the numbers of people living with AD. In 2010, nearly 15 million family and other unpaid caregivers provided an estimated 17 billion hours of care to people with AD and other dementias, a contribution valued at more than $202 billion. Medicare payments for services to beneficiaries aged ≥65 years with AD and other dementias are almost 3 times higher than for beneficiaries without these conditions. Total payments in 2011 for health care, long‐term care, and hospice services for people aged ≥65years with AD and other dementias are expected to be $183 billion (not including the contributions of unpaid caregivers). This report provides information to increase understanding of the public health effect of AD, including incidence and prevalence, mortality, health expenditures and costs of care, and effect on caregivers and society in general. The report also examines the current state of AD detection and diagnosis, focusing on the benefits of early detection and the factors that present challenges to accurate diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168 · cited 6×
“2 million to a projected 11 to 16 million, barring the development of medical breakthroughs to prevent or more effectively treat the disease [41].”
InfluentialPetersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · cited 1×
“the presence of a biomarker or imaging evidence of disease [169].”
Pendlebury, S. T., & Rothwell, P. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70236-4 · Cited by 1,853
Is caregiving hazardous to one’s physical health? A meta-analysis
Vitaliano, P. P., Zhang, J., & Scanlan, J. M. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.6.946 · Cited by 1,734 · cited 1×
“Caregiver physical health Caregivers may become potential “secondary patients” because of the negative effect that providing care may have on their general health and risk for chronic disease, health-related physiological changes, healthcare utilization, and even death [105].”
Influence of education and occupation on the incidence of Alzheimer's disease
Stern, Y. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370056032 · Cited by 1,434
Research works printed but not linked: 27
- Institute for Social Research, 2009, National Football League Player Care Foundation Study of NFL retired players
- Grossberg GT, 2010, The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panel, Primary Care Companion J Clin Psychiatry, 12
- Alzheimer's Association, 2006, Early‐onset dementia: a national challenge, a future crisis
- Manly JJ, 2004, Critical Perspectives on Racial and Ethnic Differentials in Health in Late Life
- Porell F, 2009, U.S. Centers for Medicare and Medicaid Services. Medicare chronic condition warehouse
- U.S. Census Bureau, 2010, U.S. population projections: national population projections released 2008 (based on Census 2000): Summary tables
- Wan H, 2005, Current population reports, P23‐209, 65+ in the United States: 2005
- Miniño A, 2010, Deaths: preliminary data for 2008. National vital statistics reports
- National Center for Health Statistics, 2002, Deaths: final data for 2000. National vital statistics reports, Vol 50
- Xu J, 2010, Deaths: final data for 2007. National vital statistics reports
- Bouldin ED, 2007, Caregiving across the United States: caregivers of persons with Alzheimer's disease or dementia in Hawaii, Kansas and Washington
- Bouldin ED, 2009, Caregiving across the United States: caregivers of persons with Alzheimer's disease or dementia in Illinois, Louisiana, Ohio and the District of Columbia
- Alzheimer's Association, 2009, Characteristics, costs and health service use for medicare beneficiaries with a dementia diagnosis: Report 1: Medicare Current Beneficiary Survey
- Maslow K, 2006, Improving Hospital Care for People with Dementia
- Wolff J, 2008, U.S. Centers for Medicare and Medicaid Services. Chronic condition data warehouse, data from OASIS assessments
- Alzheimer's Association, 2009, Characteristics, costs and health service use for Medicare beneficiaries with a dementia diagnosis: Report 2: National 20% Sample Medicare Fee‐for‐Service Beneficiaries
- MetLife Mature Market Institute, 2009, Market Survey of Long‐Term Care Costs: The 2009 MetLife Market Survey of Nursing Home, Assisted Living, Adult Day Services and Home Care Costs
- 10.1093/geront/44.6.739 · DOI
- Partners in Caregiving, 2002, A national study of adult day services 2001–2002
- O'Keeffe J, 2006, Adult day services: a key community service for older adults
- Henry J, 2010, Medicare Fact Sheet: Medicare at a glance
- Kaiser Commission on Medicaid and the Uninsured, 2005, The distribution of assets in the elderly population living in the community
- Kaiser Commission on Medicaid and the Uninsured, 2010, Medicaid and long‐term care services and supports
- Caplan C, 2004, Out‐of‐pocket Spending on Health Care by Medicare Beneficiaries Age 65 and Older in 2003
- Henry J, 2009, Medicare Fact Sheet: the prescription drug benefit
- Henry J, 2010, Medicare Fact Sheet: the prescription drug benefit
- DeKosky ST, 2008, Bradley: Neurology in Clinical Practice
Cited by
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
2015 Alzheimer's disease facts and figures
Alzheimer's Association (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.003 · Cited by 1,635
Self-citationSaraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609
Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
(2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.03.49 · Cited by 1,288
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
Thies, W., & Bleiler, L. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.02.001 · Cited by 982
Bherer, L., Erickson, K. I., & Liu-Ambrose, T. (2013) · Journal of Aging Research · doi:10.1155/2013/657508 · Cited by 899
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810
Global Epidemiology of Dementia: Alzheimer’s and Vascular Types
Rizzi, L., Rosset, I., & Roriz-Cruz, M. (2014) · BioMed Research International · doi:10.1155/2014/908915 · Cited by 751
Jo, T., Nho, K., & Saykin, A. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00220 · Cited by 724
Astrocyte Senescence as a Component of Alzheimer’s Disease
Bhat, R., Crowe, E. P., Bitto, A., Moh, M., Katsetos, C. D., Garcia, F. U., Johnson, F. B., Trojanowski, J. Q., Sell, C., & Torres, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045069 · Cited by 586
Pinto, T. C. C., Machado, L., Bulgacov, T. M., Rodrigues-Júnior, A. L., Costa, M. L. G., Ximenes, R. C. C., & Sougey, E. B. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218001370 · Cited by 596
Cordell, C. B., Borson, S., Boustani, M., Chodosh, J., Reuben, D., Verghese, J., Thies, W., Fried, L. B., & Workgroup, M. D. O. C. I. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.011 · Cited by 578
Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
Dubois, B., Padovani, A., Scheltens, P., Rossi, A., & Dell’Agnello, G. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150692 · Cited by 562
Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522
The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
Tarawneh, R., & Holtzman, D. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006148 · Cited by 471
Mitochondrial dynamics in neurodegeneration
Itoh, K., Nakamura, K., Iijima, M., & Sesaki, H. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.10.006 · Cited by 464
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Blennow, K., Dubois, B., Fagan, A. M., Lewczuk, P., de Leon, M. J., & Hampel, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.02.004 · Cited by 455
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442
Power, M. C., Adar, S. D., Yanosky, J. D., & Weuve, J. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.004 · Cited by 422
Whitlock, E. L., Diaz-Ramirez, L. G., Glymour, M. M., Boscardin, W. J., Covinsky, K. E., & Smith, A. K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1622 · Cited by 414
Olivares, D., K. Deshpande, V., Shi, Y., K. Lahiri, D., H. Greig, N., T. Rogers, J., & Huang, X. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322564 · Cited by 407
Goldman, J. S., Hahn, S. E., Catania, J. W., Larusse-Eckert, S., Butson, M. B., Rumbaugh, M., Strecker, M. N., Roberts, J. S., Burke, W., Mayeux, R., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821d69b8 · Cited by 393
The Role of Magnesium in Neurological Disorders
Kirkland, A. E., Sarlo, G. L., & Holton, K. F. (2018) · Nutrients · doi:10.3390/nu10060730 · Cited by 382
Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review
Reitz, C. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/369808 · Cited by 376
Lu, D., Popuri, K., Ding, G. W., Balachandar, R., Beg, M. F., Initiative, A. D. N., Weiner, M., Aisen, P., Petersen, R., Jack, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22871-z · Cited by 376
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363
Misfolded proteins in Alzheimer's disease and type II diabetes
DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15112f · Cited by 361
Loneliness and risk of dementia
Sutin, A. R., Stephan, Y., Luchetti, M., & Terracciano, A. (2020) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gby112 · Cited by 331
Neurodegenerative and neurological disorders by small inhaled particles
Heusinkveld, H. J., Wahle, T., Campbell, A., Westerink, R. H. S., Tran, L., Johnston, H., Stone, V., Cassee, F. R., & Schins, R. P. F. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.07.007 · Cited by 331
The Role of Peripheral Inflammatory Markers in Dementia and Alzheimer's Disease: A Meta-Analysis
Koyama, A., O'Brien, J., Weuve, J., Blacker, D., Metti, A. L., & Yaffe, K. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls187 · Cited by 322
Mao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 313
Alzheimer's disease: synapses gone cold
Koffie, R. M., Hyman, B. T., & Spires-Jones, T. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-63 · Cited by 308
Brain aging, Alzheimer's disease, and mitochondria
Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.012 · Cited by 306
Reddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 304
A mitochondrial etiology of Alzheimer and Parkinson disease
Coskun, P., Wyrembak, J., Schriner, S. E., Chen, H.-W., Marciniack, C., LaFerla, F., & Wallace, D. C. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.008 · Cited by 302
A Survey on Wireless Body Area Networks for eHealthcare Systems in Residential Environments
Ghamari, M., Janko, B., Sherratt, R., Harwin, W., Piechockic, R., & Soltanpur, C. (2016) · Sensors · doi:10.3390/s16060831 · Cited by 300
Sinha, S., Lopes, D. H. J., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, K., Bakshi, R., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206279b · Cited by 299
NRF2 as a Therapeutic Target in Neurodegenerative Diseases
Brandes, M. S., & Gray, N. E. (2020) · ASN Neuro · doi:10.1177/1759091419899782 · Cited by 297
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00937.x · Cited by 294
Exercise counteracts declining hippocampal function in aging and Alzheimer's disease
Intlekofer, K. A., & Cotman, C. W. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.06.011 · Cited by 286
Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study
Huang, C.-C., Chung, C.-M., Leu, H.-B., Lin, L.-Y., Chiu, C.-C., Hsu, C.-Y., Chiang, C.-H., Huang, P.-H., Chen, T.-J., Lin, S.-J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087095 · Cited by 265
A Deep Siamese Convolution Neural Network for Multi-Class Classification of Alzheimer Disease
Mehmood, A., Maqsood, M., Bashir, M., & Shuyuan, Y. (2020) · Brain Sciences · doi:10.3390/brainsci10020084 · Cited by 264
Cognitive impairment and vitamin B12: a review
Moore, E., Mander, A., Ames, D., Carne, R., Sanders, K., & Watters, D. (2012) · International Psychogeriatrics · doi:10.1017/s1041610211002511 · Cited by 260
Atypical aging in down syndrome
Zigman, W. B. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1128 · Cited by 260
Metal-associated amyloid-β species in Alzheimer's disease
Pithadia, A. S., & Lim, M. H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.016 · Cited by 259
A key role for MAM in mediating mitochondrial dysfunction in Alzheimer disease
Area-Gomez, E., de Groof, A., Bonilla, E., Montesinos, J., Tanji, K., Boldogh, I., Pon, L., & Schon, E. A. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0215-0 · Cited by 235
Wu, L., Han, Y., Zheng, Z., Peng, G., Liu, P., Yue, S., Zhu, S., Chen, J., Lv, H., Shao, L., et al. (2021) · Nutrients · doi:10.3390/nu13010228 · Cited by 227
Yuan, T., Ma, H., Liu, W., Niesen, D. B., Shah, N., Crews, R., Rose, K. N., Vattem, D. A., & Seeram, N. P. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00260 · Cited by 219
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Long, J. M., Ray, B., & Lahiri, D. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.366336 · Cited by 198
The Effects of Stress on Cognitive Aging, Physiology and Emotion (ESCAPE) Project
Scott, S. B., Graham-Engeland, J. E., Engeland, C. G., Smyth, J. M., Almeida, D. M., Katz, M. J., Lipton, R. B., Mogle, J. A., Munoz, E., Ram, N., et al. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0497-7 · Cited by 197
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease
Brewer, G. J. (2012) · BioFactors · doi:10.1002/biof.1005 · Cited by 188
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 188
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease
Selfridge, J. E., E, L., Lu, J., & Swerdlow, R. H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.057 · Cited by 175
Deaths in the United States among persons with Alzheimer's disease (2010–2050)
Weuve, J., Hebert, L. E., Scherr, P. A., & Evans, D. A. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.004 · Cited by 173
Velazquez, R., Ferreira, E., Knowles, S., Fux, C., Rodin, A., Winslow, W., & Oddo, S. (2019) · Aging Cell · doi:10.1111/acel.13037 · Cited by 156
Drabo, E. F., Barthold, D., Joyce, G., Ferido, P., Chang Chui, H., & Zissimopoulos, J. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.005 · Cited by 155
Erickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145
Lin, P., Fillit, H. M., Cohen, J. T., & Neumann, P. J. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.002 · Cited by 142
Mohajeri, M. H., Troesch, B., & Weber, P. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.016 · Cited by 141
Cross-region reduction in 5-hydroxymethylcytosine in Alzheimer's disease brain
Condliffe, D., Wong, A., Troakes, C., Proitsi, P., Patel, Y., Chouliaras, L., Fernandes, C., Cooper, J., Lovestone, S., Schalkwyk, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.002 · Cited by 131
Internet-based program for dementia caregivers
Lewis, M. L., Hobday, J. V., & Hepburn, K. W. (2010) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317510385812 · Cited by 129
Brown, K. W., Coogle, C. L., & Wegelin, J. (2016) · Aging & Mental Health · doi:10.1080/13607863.2015.1065790 · Cited by 126
Nowrangi, M. A., Lyketsos, C. G., Leoutsakos, J. S., Oishi, K., Albert, M., Mori, S., & Mielke, M. M. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.05.2186 · Cited by 120
Tayeb, H. O., Murray, E. D., Price, B. H., & Tarazi, F. I. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.789856 · Cited by 119
Cardiorespiratory Fitness and Accelerated Cognitive Decline With Aging
Wendell, C. R., Gunstad, J., Waldstein, S. R., Wright, J. G., Ferrucci, L., & Zonderman, A. B. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glt144 · Cited by 104
Bron, E. E., Steketee, R. M. E., Houston, G. C., Oliver, R. A., Achterberg, H. C., Loog, M., van Swieten, J. C., Hammers, A., Niessen, W. J., Smits, M., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22522 · Cited by 93
Downregulated serum miR‐223 servers as biomarker in Alzheimer's disease
Jia, L., & Liu, Y. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3184 · Cited by 95
A review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93
Personalized Technology to Support Older Adults With and Without Cognitive Impairment Living at Home
Kerssens, C., Kumar, R., Adams, A. E., Knott, C. C., Matalenas, L., Sanford, J. A., & Rogers, W. A. (2015) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317514568338 · Cited by 91
Mitochondrial Abnormalities in Alzheimer’s Disease
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Cardoso, S. M., & Swerdlow, R. H. (2012) · Advances in Pharmacology · doi:10.1016/b978-0-12-394816-8.00003-9 · Cited by 86
Is Family Caregiving Associated With Inflammation or Compromised Immunity? A Meta-Analysis
Roth, D. L., Sheehan, O. C., Haley, W. E., Jenny, N. S., Cushman, M., & Walston, J. D. (2019) · The Gerontologist · doi:10.1093/geront/gnz015 · Cited by 71
The effects of tai chi exercise on cognitive function in older adults: a meta-analysis
Wu, Y., Wang, Y., Burgess, E. O., & Wu, J. (2013) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2013.09.001 · Cited by 73
PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation
Jun, G., Asai, H., Zeldich, E., Drapeau, E., Chen, C., Chung, J., Park, J., Kim, S., Haroutunian, V., Foroud, T., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24219 · Cited by 67
Dysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
A review of the effectiveness of antidepressant medications for depressed nursing home residents
Boyce, R. D., Hanlon, J. T., Karp, J. F., Kloke, J., Saleh, A., & Handler, S. M. (2012) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.009 · Cited by 58
Ma, D., Lu, D., Popuri, K., Wang, L., Beg, M. F., & Initiative, A. D. N. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00853 · Cited by 56
Corbett, G. T., Roy, A., & Pahan, K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102624 · Cited by 54
Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology
Yang, H.-S., White, C. C., Klein, H.-U., Yu, L., Gaiteri, C., Ma, Y., Felsky, D., Mostafavi, S., Petyuk, V. A., Sperling, R. A., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.010 · Cited by 47
Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice
Hunter, J. M., Cirrito, J. R., Restivo, J. L., Kinley, R. D., Sullivan, P. M., Holtzman, D. M., Koger, D., Delong, C., Lin, S., Zhao, L., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.048 · Cited by 45
RIG-1 receptor expression in the pathology of Alzheimer’s disease
de Rivero Vaccari, J. P., Brand, F. J., Sedaghat, C., Mash, D. C., Dietrich, W. D., & Keane, R. W. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-67 · Cited by 43
Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s disease
Liu, H., Luo, K., & Luo, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-21256-6 · Cited by 42
Leggett, A. N., Polenick, C. A., Maust, D. T., & Kales, H. C. (2018) · The Gerontologist · doi:10.1093/geront/gnx202 · Cited by 35
Dwibedi, N., Findley, P. A., Wiener R, C., Shen, C., & Sambamoorthi, U. (2018) · Medical Care · doi:10.1097/mlr.0000000000000869 · Cited by 39
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, Y. J., Diep, Y. N., Tran, M., & Cho, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249591 · Cited by 36
Accentuate the Positive: The Association Between Informal and Formal Supports and Caregiving Gains
Leggett, A. N., Meyer, O. L., Bugajski, B. C., & Polenick, C. A. (2021) · Journal of Applied Gerontology · doi:10.1177/0733464820914481 · Cited by 36
Till Death Do Us Part: Intersecting Health and Spousal Dementia Caregiving on Caregiver Mortality
Leggett, A. N., Sonnega, A. J., & Lohman, M. C. (2020) · Journal of Aging and Health · doi:10.1177/0898264319860975 · Cited by 32
Longitudinal Associations Between Serum Cytokine Levels and Dementia
Kim, J.-W., Stewart, R., Kang, H.-J., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Yoon, J.-S., & Kim, J.-M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00606 · Cited by 29
“As dementia has a high prevalence and a progressive, irreversible course in older adults (2, 3), it has become a global challenge for public health (4, 5).”
BackgroundIllness Representations in Older Adults with Mild Cognitive Impairment
Lin, F., Gleason, C. E., & Heidrich, S. M. (2012) · Research in Gerontological Nursing · doi:10.3928/19404921-20120605-04 · Cited by 26
Siddiqui, M. S., Francois, M., Hecker, J., Faunt, J., Fenech, M. F., & Leifert, W. R. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.03.001 · Cited by 20
A novel two-day intervention reduces stress in caregivers of persons with dementia
Spalding‐Wilson, K. N., Guzmán‐Vélez, E., Angelica, J., Wiggs, K., Savransky, A., & Tranel, D. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.08.004 · Cited by 13
Pilot Testing a Couples-Focused Intervention for Mild Cognitive Impairment
Lu, Y. Y.-F., Haase, J. E., & Weaver, M. (2013) · Journal of Gerontological Nursing · doi:10.3928/00989134-20130403-01 · Cited by 11
Pilot study of an Alzheimer's disease risk assessment program in a primary care setting
Korthauer, L. E., Denby, C., Molina, D., Wanjiku, J., Daiello, L. A., Drake, J. D., Grill, J. D., & Ott, B. R. (2021) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12157 · Cited by 6
Metadata
- Authors
- Alzheimer's Association
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2011-03
- Volume
- 7
- Issue
- 2
- Pages
- 208-244
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W4211079490
- Cited by
- 908
- References
- 151
- FWCI
- 81.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Alzheimer's Association
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.